CBD cannabis droplet dosing a biological and ecological hemp plant herbal pharmaceutical CBD oil from Cannabidiol. Concept of herbal alternative medicine, Cannabidiol oil, pharmaceutical industry

Last week, a bipartisan group of four U.S. Representatives introduced the CBD Product Safety and Standardization Act, a bill to establish federal standards for CBD products. Rep. Kathleen Rice (D-NY) wrote in a press release that the goal is to “protect consumers and provide marketplace stability for farmers, producers, and retailers.”

Supplier Catalog - Naegele

“CBD products are exploding in popularity, but the lack of federal regulation surrounding them has put consumers at risk and left businesses looking for clarity,” she said. “The bipartisan CBD Product Safety and Standardization Act will establish the clear regulatory framework needed to provide stability for business and ensure unsafe products stay off the shelves.”

If passed into law, the act would allow the FDA to regulate CBD just like any other food ingredient. The agency would also be tasked with establishing CBD content limits and packaging and labeling requirements, as well as determining what foods can include CBD. The Consumer Brands Association supports the legislation.

Industry Report - Software Trends 2022